Pre-order Enquiry
Request Free Sample
Global Anti-Obesity Drugs (Anti-obesity Medication) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
SKU ID : QYR-21748858 | Publishing Date : 21-Sep-2022 | No. of pages : 134
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Anti-Obesity Drugs (Anti-obesity Medication) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Market Segment by Application
1.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Childhood (0-6)
1.3.3 Juvenile (7-17)
1.3.4 Youth (18-40)
1.3.5 Middle Aged (41-60)
1.3.6 Elderly (Above 60)
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (2017-2028)
2.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028)
2.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (2017-2028)
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Regions (2017-2022)
2.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Regions (2017-2022)
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region
2.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2023-2028)
2.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Region (2023-2028)
2.4 Global Top Anti-Obesity Drugs (Anti-obesity Medication) Regions (Countries) Ranking by Market Size
2.5 Anti-Obesity Drugs (Anti-obesity Medication) Market Dynamics
2.5.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Trends
2.5.2 Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
2.5.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
2.5.4 Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers by Sales (2017-2022)
3.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers (2017-2022)
3.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti-Obesity Drugs (Anti-obesity Medication) Sales in 2021
3.2 Global Top Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) by Revenue
3.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturers (2017-2022)
3.2.2 Top Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Covered: Ranking by Revenue
3.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2021)
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti-Obesity Drugs (Anti-obesity Medication) Market
3.7 Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historic Market Review by Type (2017-2022)
4.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2022)
4.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2022)
4.1.3 Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2017-2022)
4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Type (2023-2028)
4.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Type (2023-2028)
4.2.3 Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Type (2023-2028)
5 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historic Market Review by Application (2017-2022)
5.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2022)
5.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2022)
5.1.3 Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2017-2022)
5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Application (2023-2028)
5.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Application (2023-2028)
5.2.3 Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Company
6.1.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022)
6.1.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022)
6.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
6.2.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
6.2.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
6.3 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
6.3.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
6.3.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
6.4 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
6.4.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
6.4.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Company
7.1.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022)
7.1.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022)
7.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
7.2.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
7.2.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
7.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
7.3.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
7.3.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
7.4 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
7.4.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
7.4.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Company
8.1.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022)
8.1.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022)
8.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
8.2.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
8.2.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
8.3 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
8.3.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
8.3.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
8.4 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.4.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.4.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Company
9.1.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022)
9.1.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022)
9.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
9.2.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
9.2.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
9.3 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
9.3.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
9.3.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
9.4 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
9.4.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
9.4.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Company
10.1.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022)
10.1.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022)
10.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
10.2.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
10.2.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
10.3 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
10.3.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
10.3.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
10.4 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
10.4.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
10.4.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Zafgan
11.1.1 Zafgan Corporation Information
11.1.2 Zafgan Overview
11.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.1.5 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.1.6 Zafgan Recent Developments
11.2 Vivus
11.2.1 Vivus Corporation Information
11.2.2 Vivus Overview
11.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.2.5 Vivus Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.2.6 Vivus Recent Developments
11.3 Shionogi
11.3.1 Shionogi Corporation Information
11.3.2 Shionogi Overview
11.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.3.5 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.3.6 Shionogi Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.4.5 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 Rhythm Pharmaceuticals
11.5.1 Rhythm Pharmaceuticals Corporation Information
11.5.2 Rhythm Pharmaceuticals Overview
11.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.5.5 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.5.6 Rhythm Pharmaceuticals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.6.5 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Corporation Information
11.7.2 Orexigen Therapeutics Overview
11.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.7.5 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.7.6 Orexigen Therapeutics Recent Developments
11.8 Novo Nordisk
11.8.1 Novo Nordisk Corporation Information
11.8.2 Novo Nordisk Overview
11.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.8.5 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.8.6 Novo Nordisk Recent Developments
11.9 Norgine
11.9.1 Norgine Corporation Information
11.9.2 Norgine Overview
11.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.9.5 Norgine Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.9.6 Norgine Recent Developments
11.10 Nalpropion Pharmaceuticals Inc.
11.10.1 Nalpropion Pharmaceuticals Inc. Corporation Information
11.10.2 Nalpropion Pharmaceuticals Inc. Overview
11.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.10.5 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
11.10.6 Nalpropion Pharmaceuticals Inc. Recent Developments
11.11 Merck
11.11.1 Merck Corporation Information
11.11.2 Merck Overview
11.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.11.5 Merck Recent Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Corporation Information
11.12.2 GlaxoSmithKline Overview
11.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.12.5 GlaxoSmithKline Recent Developments
11.13 F.Hoffmann-La Roche
11.13.1 F.Hoffmann-La Roche Corporation Information
11.13.2 F.Hoffmann-La Roche Overview
11.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.13.5 F.Hoffmann-La Roche Recent Developments
11.14 Eisai
11.14.1 Eisai Corporation Information
11.14.2 Eisai Overview
11.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.14.5 Eisai Recent Developments
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Corporation Information
11.15.2 Boehringer Ingelheim Overview
11.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.15.5 Boehringer Ingelheim Recent Developments
11.16 Bayer AG
11.16.1 Bayer AG Corporation Information
11.16.2 Bayer AG Overview
11.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.16.5 Bayer AG Recent Developments
11.17 AstraZeneca
11.17.1 AstraZeneca Corporation Information
11.17.2 AstraZeneca Overview
11.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.17.5 AstraZeneca Recent Developments
11.18 Arena Pharmaceuticals
11.18.1 Arena Pharmaceuticals Corporation Information
11.18.2 Arena Pharmaceuticals Overview
11.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.18.5 Arena Pharmaceuticals Recent Developments
11.19 Amylin
11.19.1 Amylin Corporation Information
11.19.2 Amylin Overview
11.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.19.5 Amylin Recent Developments
11.20 Alizyme
11.20.1 Alizyme Corporation Information
11.20.2 Alizyme Overview
11.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Products and Services
11.20.5 Alizyme Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Anti-Obesity Drugs (Anti-obesity Medication) Value Chain Analysis
12.2 Anti-Obesity Drugs (Anti-obesity Medication) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Obesity Drugs (Anti-obesity Medication) Production Mode & Process
12.4 Anti-Obesity Drugs (Anti-obesity Medication) Sales and Marketing
12.4.1 Anti-Obesity Drugs (Anti-obesity Medication) Sales Channels
12.4.2 Anti-Obesity Drugs (Anti-obesity Medication) Distributors
12.5 Anti-Obesity Drugs (Anti-obesity Medication) Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Anti-Obesity Drugs (Anti-obesity Medication) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Prescription Drugs
Table 3. Major Manufacturers of OTC Drugs
Table 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2022) & (K Units)
Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2017-2022)
Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2017-2022)
Table 10. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Anti-Obesity Drugs (Anti-obesity Medication) Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Anti-Obesity Drugs (Anti-obesity Medication) Market Trends
Table 16. Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
Table 17. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
Table 18. Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
Table 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Manufacturers (2017-2022)
Table 21. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers by Revenue (US$ Million) in 2021
Table 23. Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers (2017-2022)
Table 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2021)
Table 26. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 27. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Plants/Factories Distribution
Table 28. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Area Served
Table 29. Date of Key Manufacturers Enter into Anti-Obesity Drugs (Anti-obesity Medication) Market
Table 30. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Type (2017-2022)
Table 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Type (2017-2022)
Table 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (K Units) by Type (2017-2022)
Table 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Type (2023-2028)
Table 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Type (2023-2028)
Table 38. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Type (2023-2028)
Table 40. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (K Units) by Type (2023-2028)
Table 41. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Application (2017-2022)
Table 42. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Application (2017-2022)
Table 43. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (K Units) by Application (2017-2022)
Table 45. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Application (2023-2028)
Table 46. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Application (2023-2028)
Table 47. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Application (2023-2028)
Table 49. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (K Units) by Application (2023-2028)
Table 50. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022) & (K Units)
Table 51. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2017-2022)
Table 52. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2017-2022)
Table 54. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 55. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 56. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 59. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 60. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)
Table 63. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2023-2028) & (K Units)
Table 64. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022) & (K Units)
Table 67. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2017-2022)
Table 68. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2017-2022)
Table 70. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 71. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 72. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 75. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 76. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)
Table 79. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2023-2028) & (K Units)
Table 80. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2017-2022)
Table 100. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2017-2022)
Table 102. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2023-2028) & (US$ Million)
Table 130. Zafgan Corporation Information
Table 131. Zafgan Description and Overview
Table 132. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 133. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 134. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 135. Zafgan Recent Developments
Table 136. Vivus Corporation Information
Table 137. Vivus Description and Overview
Table 138. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 139. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 140. Vivus Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 141. Vivus Recent Developments
Table 142. Shionogi Corporation Information
Table 143. Shionogi Description and Overview
Table 144. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 145. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 146. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 147. Shionogi Recent Developments
Table 148. Sanofi Corporation Information
Table 149. Sanofi Description and Overview
Table 150. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 151. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 152. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 153. Sanofi Recent Developments
Table 154. Rhythm Pharmaceuticals Corporation Information
Table 155. Rhythm Pharmaceuticals Description and Overview
Table 156. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 157. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 158. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 159. Rhythm Pharmaceuticals Recent Developments
Table 160. Pfizer Corporation Information
Table 161. Pfizer Description and Overview
Table 162. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 163. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 164. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 165. Pfizer Recent Developments
Table 166. Orexigen Therapeutics Corporation Information
Table 167. Orexigen Therapeutics Description and Overview
Table 168. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 169. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 170. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 171. Orexigen Therapeutics Recent Developments
Table 172. Novo Nordisk Corporation Information
Table 173. Novo Nordisk Description and Overview
Table 174. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 175. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 176. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 177. Novo Nordisk Recent Developments
Table 178. Norgine Corporation Information
Table 179. Norgine Description and Overview
Table 180. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 181. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 182. Norgine Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 183. Norgine Recent Developments
Table 184. Nalpropion Pharmaceuticals Inc. Corporation Information
Table 185. Nalpropion Pharmaceuticals Inc. Description and Overview
Table 186. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 187. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 188. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 189. Nalpropion Pharmaceuticals Inc. Recent Developments
Table 190. Merck Corporation Information
Table 191. Merck Description and Overview
Table 192. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 193. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 194. Merck Recent Developments
Table 195. GlaxoSmithKline Corporation Information
Table 196. GlaxoSmithKline Description and Overview
Table 197. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 198. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 199. GlaxoSmithKline Recent Developments
Table 200. F.Hoffmann-La Roche Corporation Information
Table 201. F.Hoffmann-La Roche Description and Overview
Table 202. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 203. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 204. F.Hoffmann-La Roche Recent Developments
Table 205. Eisai Corporation Information
Table 206. Eisai Description and Overview
Table 207. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 208. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 209. Eisai Recent Developments
Table 210. Boehringer Ingelheim Corporation Information
Table 211. Boehringer Ingelheim Description and Overview
Table 212. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 213. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 214. Boehringer Ingelheim Recent Developments
Table 215. Bayer AG Corporation Information
Table 216. Bayer AG Description and Overview
Table 217. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 218. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 219. Bayer AG Recent Developments
Table 220. AstraZeneca Corporation Information
Table 221. AstraZeneca Description and Overview
Table 222. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 223. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 224. AstraZeneca Recent Developments
Table 225. Arena Pharmaceuticals Corporation Information
Table 226. Arena Pharmaceuticals Description and Overview
Table 227. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 228. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 229. Arena Pharmaceuticals Recent Developments
Table 230. Amylin Corporation Information
Table 231. Amylin Description and Overview
Table 232. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 233. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 234. Amylin Recent Developments
Table 235. Alizyme Corporation Information
Table 236. Alizyme Description and Overview
Table 237. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 238. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 239. Alizyme Recent Developments
Table 240. Key Raw Materials Lists
Table 241. Raw Materials Key Suppliers Lists
Table 242. Anti-Obesity Drugs (Anti-obesity Medication) Distributors List
Table 243. Anti-Obesity Drugs (Anti-obesity Medication) Customers List
Table 244. Research Programs/Design for This Report
Table 245. Key Data Information from Secondary Sources
Table 246. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Obesity Drugs (Anti-obesity Medication) Product Picture
Figure 2. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2021 & 2028
Figure 3. Prescription Drugs Product Picture
Figure 4. OTC Drugs Product Picture
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2021 & 2028
Figure 6. Childhood (0-6) Use Case
Figure 7. Juvenile (7-17) Use Case
Figure 8. Youth (18-40) Use Case
Figure 9. Middle Aged (41-60) Use Case
Figure 10. Elderly (Above 60) Use Case
Figure 11. Anti-Obesity Drugs (Anti-obesity Medication) Report Years Considered
Figure 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size 2017-2028 (US$ Million)
Figure 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (2017-2022) & (K Units)
Figure 15. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2017-2022)
Figure 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2021
Figure 18. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region in 2017 VS 2021
Figure 19. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Manufacturers in 2021
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Sales in 2021
Figure 21. Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers in 2021
Figure 22. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Type (2017-2022)
Figure 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate by Type in 2017 & 2021
Figure 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Application (2017-2022)
Figure 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate by Application in 2017 & 2021
Figure 27. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
Figure 28. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
Figure 29. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
Figure 30. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
Figure 31. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Country (2017-2028)
Figure 32. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Country (2017-2028)
Figure 33. U.S. Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 34. Canada Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 35. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
Figure 36. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
Figure 37. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
Figure 38. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
Figure 39. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Country (2017-2028)
Figure 40. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Country (2017-2028)
Figure 41. Germany Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 42. France Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 43. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 44. Italy Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 45. Russia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 46. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
Figure 47. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
Figure 48. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
Figure 49. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
Figure 50. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Region (2017-2028)
Figure 51. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Region (2017-2028)
Figure 52. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 53. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 54. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 55. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 56. Australia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 57. China Taiwan Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 58. Indonesia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 59. Thailand Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 60. Malaysia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2017-2028) & (US$ Million)
Figure 61. Latin America Anti-Obesity Drugs (Anti-obesity Medication
Keyplayers in Global Anti-Obesity Drugs (Anti-obesity Medication) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
ZafganVivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
